OVERVIEW

The 2024 Clinical Hematology & Oncology Conference is designed for hematologists, oncologists, surgeons, radiation oncologists, internists, and others desiring an update in these specialty areas. The primary objective of this course is to bring together clinicians and leading experts in diverse areas of hematology and oncology, affording them an intimate environment in which to discuss new clinical developments and significant advances.

TARGET AUDIENCE

• Hematologists/Oncologists
• Medical Oncologists
• Surgeons
• Radiation Oncologists
• Internists
• And others desiring an update in these specialty areas

LEARNING OBJECTIVES

After attending this live activity, participants should be able to:

• Describe the clinical and molecular facets of pathogenesis, diagnostic approaches and therapeutic modalities available for various hematologic disorders.
• Select and apply the changing approaches to hematologic malignancies, particularly as they relate to evidence-based standards of care, including innovations in diagnosis and treatment.
• Choose new therapeutic options for the treatment of a number of common malignancies; understanding appropriate indications and contraindications to these therapeutic approaches.
• Integrate the evolving approaches to breast cancer from both a diagnostic, prognostic and therapeutic perspective.
• Integrative the evolving approaches to various immunologic cancer treatments. 

ACCREDITATION

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Scripps Health designates this live activity for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.